After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
MRUS belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Merus N.V is $4.06B. A total of 1.3 million shares were traded on the day, compared to an average of 1.16M shares.
In the most recent transaction, Silverman Peter B. bought 6,695 shares of MRUS for 55.00 per share on Jul 09 ’25. In a previous transaction on Jun 20 ’25, Silverman Peter B. sold 34,000 shares at 52.76 per share. MRUS shares that COO & GC owns now total 0.
Among the insiders who bought shares, Silverman Peter B. acquired of 34,000 shares on Jun 20 ’25 at a per-share price of $52.76. In another insider transaction, Shuman Harry sold 4,000 shares at $48.50 per share on Mar 21 ’25. Company shares held by the VP Controller, PAO now total 11,002.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, MRUS has a high of $62.98 and a low of $33.19.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. MRUS’s latest balance sheet shows that the firm has $410.43M in Cash & Short Term Investments as of fiscal 2021. There were $3.75M in debt and $71.90M in liabilities at the time. Its Book Value Per Share was $8.62, while its Total Shareholder’s Equity was $316.20M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MRUS is Buy with a score of 4.94.
